The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 35, No. 4, pp. 427-431. DOI 10.1345/aph.10217
© 2001 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, L.

Research Articles

Gabapentin for treatment of behavioral and psychological symptoms of dementia

LJ Miller

OBJECTIVE: To report the use of gabapentin in the treatment of behavioral and psychological symptoms of dementia (BPSD) and to review the available literature relating to the use of gabapentin in this population. CASE SUMMARY: A 62-year-old white man was admitted to the hospital due to a worsening state of confusion, anxiety, depressed mood, insomnia, and verbal and physical aggressiveness toward his wife. He had a past medical history significant for vascular dementia. He had been intolerant of or had failed to respond to numerous antidepressants, benzodiazepines, and neuroleptics. The addition of gabapentin to the patient's medication regimen resulted in reduced agitation, sexual inappropriateness, and lability. He was discharged to his home on a dose of gabapentin 300 mg three times daily. DATA SOURCES: A MEDLINE search (1966-August 2000) was performed to identify case reports and clinical trials discussing the efficacy of gabapentin in the treatment of BPSD. DISCUSSION: Gabapentin, like other anticonvulsants, has been used with success in several psychiatric illnesses. Available literature indicates that the drug may have some efficacy in the treatment of BPSD. It has a favorable adverse effect profile in the elderly, which makes it an attractive altemative to standard therapies, including benzodiazepines and neuroleptics. Optimal dosing remains unclear. CONCLUSIONS: This case suggests that gabapentin is a reasonable alternative therapy for patients whose behavioral symptoms do not respond to conventional agents.


This article has been cited by other articles:


Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
B. Ozkan, K. Wilkins, S. Muralee, and R. R. Tampi
Pharmacotherapy for Inappropriate Sexual Behaviors in Dementia: A Systematic Review of Literature
American Journal of Alzheimer's Disease and Other Dementias, August 1, 2008; 23(4): 344 - 354.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
L. M Lieving, D. R Cherek, S. D Lane, O. V Tcheremissine, and S. O Nouvion
Effects of acute tiagabine administration on aggressive responses of adult male parolees
J Psychopharmacol, March 1, 2008; 22(2): 144 - 152.
[Abstract] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
H. Series and P. Degano
Hypersexuality in dementia
Advan. Psychiatr. Treat., November 1, 2005; 11(6): 424 - 431.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
G. T. Grossberg and A. K. Desai
Management of Alzheimer's Disease
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M331 - 353.
[Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2001 by Harvey Whitney Books Company.